MARKET

FEED

FEED

ENvue Medical
NASDAQ
1.190
-0.130
-9.85%
After Hours: 1.240 +0.05 +4.17% 19:55 05/08 EDT
OPEN
1.360
PREV CLOSE
1.320
HIGH
1.535
LOW
1.160
VOLUME
937.87K
TURNOVER
--
52 WEEK HIGH
45.60
52 WEEK LOW
0.9900
MARKET CAP
4.40M
P/E (TTM)
-0.0446
1D
5D
1M
3M
1Y
5Y
1D
ENvue Medical secures notice of allowance from USPTO
TipRanks · 2d ago
ENvue Medical Issued Notice Of Allowance From U.S. Patent And Trademark Office For Its Proprietary Surface Acoustic Wave Technology
Benzinga · 2d ago
ENvue Medical wins USPTO notice of allowance for ultrasound-enhanced cannabinoid delivery patent
PUBT · 2d ago
ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology
Barchart · 2d ago
ENvue Medical announces three-year purchasing agreement renewal
TipRanks · 3d ago
Envue Medical renews three-year GPO purchasing agreement with major US health system
PUBT · 3d ago
ENVUE MEDICAL SECURES THREE-YEAR PURCHASING AGREEMENT RENEWAL WITH THE GROUP PURCHASING ORGANIZATION (GPO) FOR ONE OF THE LARGEST HEALTH SYSTEMS IN THE U.S. OPERATING OVER 90 HOSPITALS
Reuters · 3d ago
EXCLUSIVE: ENvue Medical Locks In Multi-Year Access To Large US Nonprofit Hospital System Through 2028
Benzinga · 3d ago
More
About FEED
ENvue Medical, Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.

Webull offers ENvue Medical Inc stock information, including NASDAQ: FEED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEED stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEED stock methods without spending real money on the virtual paper trading platform.